recipients, leading to special need of non-invasive validated methods to estimate liver
fibrosis. AIM: To assess the efficacy of liver stiffness measurement by transient elastography
(Fibroscan) and serum parameters in predicting fibrosis stage in HCV-infected transplant
recipients. METHODS: The correlation between liver fibrosis, assessed at liver histology on
bioptic specimens obtained for clinical indications, and stiffness or clinico-serological …